RxDoctor Payments Data

Adam Robinson, DO

Internal Medicine · Colorado Springs, CONPI 1326300682

Payments from drug & device makers

$2,869in general payments, 2019–2025

Across 162 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$236
  • GSK$202
  • Novo Nordisk$202
  • AstraZeneca$187
  • Merck$176
  • Amgen$170
  • plus $2K from 42 others

What the payments were for

  • Food & beverage$2,869100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,869 in reported general payments places this provider in the 90th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$127,209
Medicare patients
217
Services billed
1,567

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$63,867
EliquisApixaban36$51,467
JardianceEmpagliflozin29$39,230
XareltoRivaroxaban17$29,344
FarxigaDapagliflozin Propanediol21$15,240
TrulicityDulaglutide11$14,062
LinzessLinaclotide14$10,196
SymbicortBudesonide/Formoterol Fumarate11$4,352
Gabapentin66$3,070
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,667
Famotidine33$2,474
Levothyroxine Sodium215$2,076
Albuterol Sulfate HfaAlbuterol Sulfate48$1,817
Atorvastatin Calcium207$1,792
Omeprazole92$1,337

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$202$63,86736 claims
PfizerEliquis$86$51,46736 claims
Boehringer IngelheimJardiance$15$39,23029 claims
Johnson & JohnsonXarelto$113$29,34417 claims
AstraZenecaFarxiga, Symbicort$187$19,59232 claims
Lilly USA, LLCTrulicity$27$14,06211 claims
AbbVieLinzess, Synthroid$236$11,18035 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,430 internal medicine providers in Colorado.

Other internal medicine in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →